Lincocin

Lincomycin, the active ingredient in Lincocin, is a lincosamide presented as an injection solution for intravenous use. It treats bacterial infections such as skin and soft tissue infections, bone and joint infections, intra‑abdominal infections, and respiratory tract infections in adults and children as prescribed, and is indicated for use under medical supervision.

GNH USA supplies Lincocin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics, and health‑care institutions worldwide, ensuring quality and regulatory compliance across markets, with reliable delivery.

Lincocin is used to treat bacterial infections in several organ systems, targeting susceptible Gram‑positive and anaerobic organisms.

- Skin and soft tissue infections: resolves infection caused by susceptible bacteria and reduces inflammation. - Bone and joint infections: treats osteomyelitis and septic arthritis due to susceptible organisms. - Intra‑abdominal infections: effective for peritonitis and intra‑abdominal abscesses caused by target pathogens. - Respiratory tract infections: used for pneumonia and bronchitis when caused by susceptible bacteria.

Lincomycin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea and vomiting: gastrointestinal upset that may occur during or after infusion. - Diarrhea: loose stools ranging from mild to moderate severity, occasionally leading to dehydration. - Injection site reactions: pain, erythema, swelling, or induration at the intravenous site.

Serious or Rare Side Effects: - Clostridioides difficile-associated colitis: severe, potentially life‑threatening diarrhea with pseudomembranous colitis. - Anaphylaxis: rapid hypersensitivity reaction causing bronchospasm, hypotension, and possible shock. - Hepatic dysfunction: marked elevation of transaminases, jaundice, or hepatitis requiring monitoring.

When using Lincocin, clinicians should consider several precautionary measures to ensure safe and effective therapy. - Pregnancy: Category B; use only when benefit outweighs potential risk to the fetus. - Renal impairment: assess kidney function; dose adjustment may be necessary in moderate to severe dysfunction. - Hepatic impairment: monitor liver enzymes; consider reduced dosage in patients with existing liver disease. - Hypersensitivity: discontinue immediately if signs of allergic reaction such as rash, pruritus, or anaphylaxis appear. - Concomitant nephrotoxic or ototoxic drugs: avoid or monitor closely due to increased risk of toxicity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Lincomycin can interact with other medicines, altering its efficacy or increasing toxicity.

Major Interactions (Avoid): - Aminoglycosides (e.g., gentamicin): combined use may enhance nephrotoxicity. - Neuromuscular blocking agents: may potentiate muscle relaxation and respiratory depression. - Clindamycin: additive risk of Clostridioides difficile colitis.

Moderate Interactions (Monitor Closely): - Warfarin: lincomycin may increase anticoagulant effect; monitor INR regularly. - Loop diuretics: may affect electrolyte balance; observe serum potassium. - Probenecid: can reduce renal clearance of lincomycin, raising plasma levels.